Savard, Josephine, Katarina Görts Öberg, Andreas Chatzittofis, Cecilia Dhejne, Stefan Arver, a me Jussi Jokinen.
ʻO ka Journal of Medicine Medicine (2020).
Hōʻuluʻulu Manaʻo
kāʻei kua
ʻO ka hana hōʻemi kino ka hana maʻa (CSBD) kahi maʻi maʻamau e pili ana i nā wahi like ʻole o ke ola, ʻoiai ʻo nā noi e pili ana i ka lapaʻau pharmacological he sparse.
AIM
E nānā inā he kūpono a hoʻokipa a opioid receptor antagonist naltrexone a hiki ke hāʻawi i ka hōʻemi hōʻailona ma CSBD.
Nā Papahana
Iwakāluakūmālua mau kāne he 27-60 mau makahiki (mean = 38.8 mau makahiki, hoʻololi maʻamau = 10.3) me CSBD e ʻimi nei i ka lāʻau lapaʻau ma kahi keʻena nonforensic maʻi maʻi i loaʻa i ʻehā mau pule o ka naltrexone 25-50 mg. Ua ana ʻia nā ana ma mua, i ka wā, a i ʻehā mau pule ma hope o ka mālama ʻana.
Nā hopena
ʻO ka hōʻaiʻē hōʻaiʻē Hypersexual Disorder: Nā Helu nei ʻĀina Wāwili (HD: CAS) ka helu no ka hopena mua loa, a ʻo nā hopena pae lua ke helu Hypersexual Behaviour Inventory (HBI), hōʻike i nā hopena maikaʻi loa, pili ʻole i ka mālama ʻana, a me nā hoʻoemi ʻana.
Results
Ua nui ka emi ʻana o nā ʻelua ma ka HD: CAS a me nā HBI i ka wā o ka mālama ʻana me ka naltrexone. ʻOiai inā noho kekahi o nā hopena ma hope o ka mālama ʻana, ʻo ka hoʻonui nui ʻana ma ka HD: Ua hōʻike ka CAS i ka nui o nā hōʻailona o ka CSBD. ʻO ka hopena maikaʻi loa i hōʻike ʻia ka momona (55%), nausea (30%), vertigo (30%), a me ka ʻeha o ka ʻōpū (30%). Eia naʻe, ʻaʻohe hopena koʻikoʻi e pili ana i ka hoʻokuʻu ʻana o naltrexone.
Nā hopena hōʻailona
ʻOiai nā hopena hopena i maʻamau, ʻike ʻia ka naltrexone e hiki ke kō i ka mālama ʻana i ka CSBD.
Nā ikaika & palena
ʻO ia ka hoʻokūkū hoʻokūkū mua nonforensic e pili ana i ka naltrexone ma CSBD, kēia loiloi e hāʻawi i nā ʻike no nā moʻolelo hou e pili ana i kahi hōʻiliʻili pharmacological. Eia nō naʻe, no ka nui o ka nui lahilahi a me ka nele o kahi pūʻulu mana, nā hopena o ka hoʻokō pono e wehewehe pono me ka akaʻala.
Panina
Hana ʻia a Naltrexone a kūpono a hoʻemi paha i nā hōʻailona o ka CSBD; akā naʻe, pono e aʻo nā noiʻi i hope e loiloi i kahi kaʻina hana loiloi e loiloi i ka hiki ke kūpono.
Nā Huaʻōlelo - Ka hoʻohaʻahaʻa moekolohe kolohe, Naltrexone, maʻi Hypersexual, ʻino moekolohe
Nānā: Ma kahi haʻawina nui i kākau ʻia ma ʻO ke kaiākamai honua, nā hoʻomaikaʻi, ʻoiai hiki ke ana ʻia, ʻaʻole i hiki i ke koʻikoʻi helu.
ʻO ka hoʻomanawanui a me ka maikaʻi o ka paroxetine a me ka naltrexone no ka mālama ʻana i ka maʻi ʻino koʻikoʻi (2022)
Ma muli o nā nīnauele lapaʻau, ua ʻike ʻia nā lāʻau ʻelua i ʻoi aku ka maikaʻi ma mua o ka placebo i ka hōʻemi ʻana i nā hōʻailona CSBD. Ua ʻike ʻia kēlā ʻano kiʻekiʻe o nā lima lapaʻau ʻelua ma mua o ka placebo i ka pule 20th, akā ma mua o ka pule 8th.
;